A Prince George doctor and parent of a prematurely born child is calling for a new life-saving vaccine to be made available ...

Toronto Public Health recorded over 570 cases of influenza and a nearly 11 per cent COVID-19 positivity rate in the second week of January.

Explore the uptake of maternal RSV vaccination and infant protection trends during the 2023-2024 RSV season, focusing on ...

About 8 in 10 infants received respiratory syncytial virus protection during the 2023 to 2024 season, according to study findings.

Live-attenuated respiratory syncytial virus (RSV) vaccines are highly immunogenic among HIV-exposed uninfected (HEU) pediatric patients, according to results of a study published in Open Forum ...

The RSV vaccine is not recommended as an annual vaccine but it is available and encouraged for three types of adults: adults ages 75 and older; adults ages 65 to 74 who have chronic heart or lung ...

CEO Stéphane Bancel emphasised saving cash as integral in the company’s bid to parlay Covid-19 profits into future profitability.

The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...

A stomach illness outbreak at the University of Guelph is part of a trend that has experts noticing a rise in stomach bugs ...

Pfizer Inc. (NYSE:PFE) released topline results from its Phase 3 CREST trial evaluating sasanlimab, an investigational ...

HealthDay News — Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according to a research letter published online January 8 in JAMA Network ...

Respiratory diseases are on the rise in Oneida County and beyond. The county has provided tips to keep you and your family ...